According to the report published by Allied Market Research, the global cancer insurance market garnered $61.7 billion in 2022 and is expected to generate a revenue of $159.9 billion by 2032, growing at a noteworthy CAGR of 10.2% from 2023 to 2032. The comprehensive study analyzes the actionable insights, drivers, competitive scenario, market dynamics, size, and promising investment regions.
Request Research Report Sample & TOC: https://www.alliedmarketresearch.com/request-sample/A264275
Highlights:
- The insurance plan segment of the global cancer insurance market is further divided into individual plan, supplement plan, and critical illness plan.
- The individual plan segment held the maximum market share in 2022.
- Based on region, the Europe region is predicted to grow with the fastest CAGR during the forecast period.
Futuristics Trends in Cancer Insurance:
- Customized Policies: Nowadays, several insurance companies are offering more customizable cancer insurance policies to meet the diverse needs of consumers. These policies would allow individuals to choose coverage amounts, benefit periods, and specific types of cancer coverage based on their preferences and budget.
- Comprehensive Coverage: With the changing consumer demands, many insurers are expanding the scope of coverage provided by cancer insurance policies, including a broader range of services and expenses. These coverage plans include diagnostic tests, alternative therapies, genetic counselling, and rehabilitation services to support individuals throughout their cancer journey.
- Integration with Critical Illness Insurance: Some insurers are integrating cancer insurance with critical illness insurance to provide comprehensive coverage for a wide range of serious medical conditions. Such approaches are expected to offer policyholders greater flexibility and peace of mind by addressing multiple health risks under a single insurance policy.
Segments of the Cancer Insurance Market:
Insurance Plan:
- Individual Plan: An individual plan in cancer insurance is a policy purchased directly by an individual to cover personal cancer-related expenses. It typically offers a lump-sum payment upon diagnosis, coverage for treatment expenses such as surgery and chemotherapy. It also includes additional benefits such as home healthcare and counseling services.
- Supplement Plan: This insurance plan complements existing health insurance by providing additional coverage for cancer-related expenses not fully covered by primary insurance. Such plans offer benefits such as coverage for treatment costs, broader coverage amounts, and assistance with non-medical expenses, helping alleviate financial burdens associated with cancer diagnosis and treatment.
- Critical Illness Plan: This type of policy also provides coverage for other serious illnesses along with cancer, such as cardiovascular diseases, neurological disorders, etc. With this plan, patients can avail coverage for the diagnosis of critical health conditions, medical expenses, and other financial obligations associated with the illness, including cancer treatment costs.
Gender:
- Male: In 2022, the male segment of the cancer insurance market held the highest share due to the increased smoking and alcohol consumption in males.
- Female: The female segment is predicted to exhibit the highest CAGR during the estimated timeframe due to the increasing prevalence of breast cancer among females globally.
𝐁𝐮𝐲 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐏𝐫𝐢𝐜𝐞 @ https://bit.ly/3V2iHpN
The individual plan segment to maintain its leadership status throughout the forecast period
Based on insurance plan segment, the individual plan segment attained more than half of the market-share and will continue to dominate the market for the forecast period as the plan is affordable for middle- and lower-class income earning groups. However, from 2023 to 2032, the critical illness plan is expected to grow at the fastest rate of 12.3%. This is due to the lump sum benefit provided by the plan.
The male segment to maintain its leadership status throughout the forecast period
Based on gender, the male segment held the highest market share in 2022, accounting for more than three-fifths of the cancer insurance market revenue, and is estimated to maintain its leadership status throughout the forecast period. This is because of increasing smoking and alcohol intake among the males. However, from 2023 to 2032, the female segment is expected to grow at the fastest rate of 11.7%. This is because of increasing lack of proper diet among the young females.
The North America segment to maintain its leadership status throughout the forecast period
Based on region, North America held the highest market share in 2022, accounting for around one-third of the cancer insurance market revenue, and is estimated to maintain its leadership status throughout the forecast period. This is because of increasing cancer cases in the region. However, from 2023 to 2032, the Asia-Pacific segment is expected to grow at the fastest rate of 12.9%. This is because of increasing population, pollution and health problems in the region.
The Growing Landscape of Different Regions:
The global cancer insurance market is evaluated across various regions including North America, Asia-Pacific, Europe, and LAMEA. The North America region dominated the market in 2022 because of the increased number of cancer cases across the region. However, the Europe region is expected to grow at a healthy CAGR due to the rising cases of different types of cancers among middle-aged individuals throughout the region.
Key Determinants Boosting the Growth of the Cancer Insurance Market:
The global cancer insurance market has experienced significant growth due to the rapid technological advancements in cancer treatment. For instance, gene editing tools have become one of the latest technologies that have helped specialists to modify genes used for cancer development. Furthermore, the increasing risk of cancer among adults is expected to increase the demand for cancer insurance in the forthcoming years. On the other hand, unlike traditional health insurance, advanced cancer insurance policies cover experimental and cutting-edge therapies which are expected to drive the growth of the market exponentially during the estimated period.
𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A264275
Prominent Market Players:
- CVS Health
- Prudential Plc
- United Health
- UNUM Group
- Aviva Plc
- Mutual of Omaha
- China Life
- Aflac
- AXA
- Cigna Group
Some Other Important Questions Covered in the Comprehensive Study:
- What are the potential investment options across different regions?
- What are the new strategies of key companies in the market?
- Which company accounted for the highest market share?
- What are the key opportunities in the market?
- Which region or sub-segment is expected to drive the market in the forecast period?
𝐓𝐨𝐩 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Insurance Third Party Administrator Market
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
1209 Orange Street, Corporation Trust Center, Wilmington, New Castle, Delaware 19801 USA.
Int’l: +1-503-894-6022 Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060 Fax: +1-800-792-5285 help@alliedmarketresearch.com